Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Terminated 2Unknown 1Suspended 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 141INDUSTRY 71NIH 16NETWORK 4OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Sarcoma, Kaposi 1Lymphoma, AIDS-Related 1HIV Infections 1Castleman Disease 1

Interventions

Gemcitabine 4Cisplatin 4Rituximab 2Fluorouracil 2Everolimus 2tislelizumab 1phosphorylethanolamine 1parsaclisib 1human papillomavirus vaccine, L1 type 16, 18 1famitinib 1dalpiciclib 1Zinc Sulfate 1Zinc 1Vitamin B 6 1Tamoxifen 1Sunitinib 1Sorafenib 1Radiotherapy, Adjuvant 1Pyridoxine 1Proton Pump Inhibitors 1Prednisone 1Platelet Transfusion 1Photochemotherapy 1Pemetrexed 1Patient Portals 1Paclitaxel 1Oxaliplatin 1Neoadjuvant Therapy 1N-hydroxy-4-acetylaminostilbene 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER_GOV × Rituximab × Clear all
NCT00127569 2007-01-12

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

French National Agency for Research on AIDS and Viral Hepatitis

Phase 2 Terminated
25 enrolled
LymphoidSarcoma

Castleman Disease, Sarcoma, Kaposi, HIV Infections

NCT00126243 2005-08-17

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

French National Agency for Research on AIDS and Viral Hepatitis

Phase 2 Terminated
60 enrolled
Lymphoid

Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡